Status:
UNKNOWN
LI-ESWT Versus Sham Therapy in Men With ED
Lead Sponsor:
Hospital Authority, Hong Kong
Conditions:
Erectile Dysfunction
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
Hong Kong has an aging population. By the year of 2036, more than 30% of our population will be older than 65 years old1. Aging in male has been shown to correlate with the risk of erectile dysfunctio...
Detailed Description
Objectives 1. To investigate the efficacy and safety of LI-ESWT in treatment of moderate and severe ED 2. To investigate the effect of LI-ESWT on nocturnal penile tumescence and rigidity. Research P...
Eligibility Criteria
Inclusion
- Age \> 50 years old
- ED \> 6 months
- Stable heterosexual relationship \> 6 months
- Sexual Health Inventory for Men (SHIM) score \<= 16
- Suboptimal response after first line phosphodiesterase type 5 inhibitor treatment
Exclusion
- Penile anatomical abnormality
- History of pelvic radiotherapy
- History of radical prostatectomy
- History of penile implantations
- Neurological diseases
- Hypogonadism or on anti-androgen therapy
- Unstable psychiatric conditions or under active psychiatric treatment
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04721834
Start Date
January 1 2021
End Date
January 1 2025
Last Update
January 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.